4.8 Article

Peptidic Sulfhydryl for Interfacing Nanocrystals and Subsequent Sensing of SARS-CoV-2 Protease

Journal

CHEMISTRY OF MATERIALS
Volume 34, Issue 3, Pages 1259-1268

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.chemmater.1c03871

Keywords

-

Funding

  1. UC Office of the President [R00RG2515]
  2. National Institutes of Health [R01 DE031114, R21 AG065776, R21 AI157957, S10 OD023555]
  3. National Science Foundation Graduate Research Fellowship Program [DGE-1650112]
  4. Achievement Reward for College Scientists (ARCS) Foundation
  5. NIH [T32 CA15391]
  6. National Science Foundation [ECCS-1542148]

Ask authors/readers for more resources

This study reports a divalent substrate that can interact with M-pro, facilitating the rapid and visual detection of SARS-CoV-2 coronavirus in COVID-19. The method shows comparable sensitivity to other reported methods and exhibits high specificity to M-pro.
There is a need for surveillance of COVID-19 to identify individuals infected with SARS-CoV-2 coronavirus. Although specific, nucleic acid testing has limitations in terms of point-of-care testing. One potential alternative is the nonstructural protease (nsp5, also known as M-pro/3CL(pro)) implicated in SARS-CoV-2 viral replication but not incorporated into virions. Here, we report a divalent substrate with a novel design, (Cys)(2)-(AA)(x)-(Asp)(3), to interface gold colloids in the specific presence of M-pro leading to a rapid and colorimetric readout. Citrate- and tris(2-carboxyethyl)phosphine (TCEP)-AuNPs were identified as the best reporter out of the 17 ligated nanoparticles. Furthermore, we empirically determined the effects of varying cysteine valence and biological media on the sensor specificity and sensitivity. The divalent peptide was specific to M-pro, that is, there was no response when tested with other proteins or enzymes. Furthermore, the M-pro detection limits in Tris buffer and exhaled breath matrices are 12.2 and 18.9 nM, respectively, which are comparable to other reported methods (i.e., at low nanomolar concentrations) yet with a rapid and visual readout. These results from our work would provide informative rationales to design a practical and noninvasive alternative for COVID-19 diagnostic testing.the presence of viral proteases in biofluids is validated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available